The Rosen Law Firm launched an investigation into potential securities fraud committed by Catalyst Pharmaceutical Partners Inc. (Nasdaq: CPRX) sending the stock price tumbling 38 cents to close at $1.52.
Catalyst Pharmaceutical Accused Of Securities Fraud
October 21, 2013 at 12:17 PM EDT